THE WHAT? Galderma has announced that it has signed a definitive agreement to acquire Alastin Skincare. Financial terms of the deal were not disclosed.
THE DETAILS Alastin’s premium skin care portfolio is fully incremental to and synergistic with the Galderma’s integrated dermatology platform.
Since it was founded, the specialty aesthetics company has delivered rapid and consistent growth, achieving a CAGR of 106 percent between 2016 and 2020.
THE WHY? Flemming Ornskov, CEO, Galderma, commented, “Galderma’s business consistently delivers strong results and remains at the forefront if this rapidly expanding market, driven by increasing consumer interest and acceptance of aesthetic procedures. The addition of Alastin with its synergistic portfolio and expertise in science-proven skin care, increases our ability to serve the needs of consumers and underscores our commitment to be the partner of choice for aesthetic professionals.
“This transaction will further enhance our premium product offering and providers a tremendous platform for future growth. We look forward to welcoming the Alastin team into Galderma and partnering with them to advance the science of dermatology together.”